Clinical features and prognostic impact of TP53 mutations in the myeloid malignancies

Takuto Mori

Presentation information

Oral Session

Oral Session 3-11A AML: Clinical siginificance of genetic abnormalities

Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Masashi Sanada (Nagoya Medical Center, National Hospital Organization, Japan)

[OS3-11A-4] Clinical features and prognostic impact of TP53 mutations in the myeloid malignancies

Takuto Mori¹, Yuichiro Ono¹, Hayato Maruoka², Madoka Kato¹, Atsushi Tanaka¹, Mari Morita¹, Momoko Nakamura¹, Yoshimitsu Shimomura¹, Nobuhiro Hiramoto¹, Satoshi Yoshioka¹, Noboru Yonetani¹, Akiko Matsushita¹, Hisako Hashimoto¹, Takayuki Ishikawa¹ (1.Hematol, Kobe City Medical Center General Hospital, Hyogo, Japan, 2.Clin Lab, Kobe City Medical Center General Hospital, Hyogo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.